AptaC – Aptamers and fusion aptamers binding haemostatic molecules for diagnostic and therapeutic use

Activated protein C (APC) plays a key role in vascular and inflammatory diseases. As endogenous inhibitor APC inactivates blood clotting factors Va and VIIIa controlling plasmatic haemostasis.

The inventions provide aptamers as diagnostic tools for detection of APC in biological samples also in the presence of abundant inactive protein C with high selective specificity. This allows establishment of routine diagnostics for APC to analyse disturbances in haemostasis, e.g. in sepsis or in haemophilia A. Further the inventions provide therapeutic aptamers binding to APC for the control of bleeding events, e.g. in haemophilia A or Willebrand syndrome.

Further Information: PDF

PROvendis GmbH
Phone: +49 (0)208/94105 0

Dipl.-Ing. Alfred Schillert

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

Alle Nachrichten aus der Kategorie: Technology Offerings

Zurück zur Startseite

Kommentare (0)

Schreib Kommentar

Neueste Beiträge

The groove of the self-organized active nematic ribbon

Soft matter on new ways to self-organization Nematic materials, such as the liquid crystals in our displays, contain molecules that align themselves in parallel. When they are constructed from microtubules…

Nanocrystals make volcanoes explode

Bayreuth geoscientist discovers causes of sudden eruptions Tiny crystals, ten thousand times thinner than a human hair, can cause explosive volcanic eruptions. This surprising connection has recently been discovered by…

Cheering up a frustrated quantum system

One of the holy-grail questions in condensed matter physics is how superconductivity — the property of many electrons to go into a quantum soup state that can carry electricity without…

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.